Dyslipidemia
Conditions
Interventions
Sponsors
Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of Western medicine for hypercholesterolemia or mixed hyperlipidemia; (2) TCM differentiation is the syndrome of damp turbid arthralgia; (3) Aged over 18 and under 75 years; (4) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who have suffered from acute myocardial infarction, cerebrovascular accident, severe trauma, post-PCI or other major surgery within six months and need to take lipid-lowering drugs for a long time; (2) Patients with acute coronary syndrome; (3) Those with secondary hyperlipidemia caused by nephrotic syndrome, hypothyroidism, gout, acute or chronic hepatobiliary disease, diabetes, etc.; (4) Hyperlipidemia caused by drugs (phenothiazines, ß-receptor blockers, adrenal corticosteroids, and certain contraceptives, etc.) or who are using heparin, thyroxine therapy drugs and other drugs that affect blood lipid metabolism patient; (5) Combined with serious primary diseases such as liver, kidney and hematopoietic system; (6) Pregnant or lactating women or those who plan to become pregnant during the trial period or whose spouse plans to become pregnant; (7) Those who are allergic or may be allergic to this treatment; (8) Patients with heart failure and heart function >= NYHA III; combined with severe arrhythmia (such as frequent ventricular premature, ventricular tachycardia, rapid atrial fibrillation, etc.) or other severe or unstable heart, liver, kidney, endocrine, Patients with medical diseases such as blood; (9) Patients with uncontrolled grade 3 hypertension (sitting diastolic blood pressure >= 110mmHg or systolic blood pressure >= 180mmHg; (10) People with mental illness, alcohol or drug dependence; (11) Patients with liver and kidney damage, ALT >= 1.5N, Cr > 1N (N is the upper limit of normal); (12) Those with a history of malignant tumors or related diseases; (13) Subjects participated in other clinical trials within 1 month; (14) People with infectious skin diseases or skin injuries; (15) Any other situation that the investigator believes will affect the efficacy and safety of the trial drug treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol;Triglycerides;LDL cholesterol;High density lipoprotein cholesterol; | — |
Countries
China
Contacts
Public ContactFeng Ling
Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences
Outcome results
None listed